Telerehabilitation helps treat breast cancer, reduce side effects

A recent study has shown telerehabilitation can be a valuable tool for breast cancer patients in alleviating side effects of both the cancer and its treatments.

Researchers from the University of Granada and hospitals Virgen de las Nieves and San Cecilio used the e-CUIDATE telerehabilitation system to treat pain, fatigue and strength loss and improve the quality of life of patients suffering with breast cancer.

The system features access to a Skype application that can administer an exercise program developed specifically to target the symptoms and side effects of breast cancer. Patients were able to maintain the benefits of the telerehabilitation six months after the completion of the exercise program.

“The participants have ameliorated their pain, strength, fatigue and quality of life, which reflects that an 8-weeks exercise program followed through the Internet can be successfully carried out without the need for an in-person therapeutic strategy," said Noelia Galiano Castillo, of the University at Granada.

 

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.